Anil Tiwari

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Scientist

UAMS

Also affiliated: University of Pittsburgh (2017–2021); Dr. Shroff’s Charity Eye Hospital (2021–2026); McGowan Institute for Regenerative Medicine (2019); Post Graduate Institute of Medical Education and Research (2011–2018); University of Missouri (2024–2025); University of Toledo (2021)

15 h-index 56 pubs 618 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Anil Tiwari studies the molecular mechanisms governing corneal epithelial cell fate and homeostasis. His research has focused on the role of Kruppel-like Factor 4 (KLF4) in regulating corneal epithelial cell proliferation, cell cycle progression, and the suppression of epithelial-mesenchymal transition. Tiwari has investigated how KLF4 interacts with signaling pathways, such as the TGF-β pathway, and influences the expression of cell cycle inhibitors like p16 and p27. His work also explores potential therapeutic strategies for ocular surface regeneration and corneal diseases, including the application of limbal-derived stem cells and the emerging therapeutic potential of exosomes. Additionally, his research has touched upon the chemopreventive properties of isothiocyanates and the use of advanced imaging techniques in managing corneal disorders.

Metrics

h-index: 15
Publications: 56
Citations: 618

Positions

Scientist 2020–present

Dr Shroff Charity Eye Hospital Cornea and Stem Cells ORCID
Scientist publications 2026

University of Arkansas for Medical Sciences ORCID

Selected Publications

Tear Cytokine Signature in Vernal Keratoconjunctivitis: A Chemokine-Remodeling Axis Associated with Disease Severity (2026)

International Journal of Molecular Sciences DOI OpenAlex

View all publications on OpenAlex →